RAD51 overexpression has been linked to poor overall survival in colorectal cancer (Tennstedt et al., 2013) and identified as one of the most predictive factors in preoperative chemoradiation therapy for advanced rectal cancer (Iwata et al., 2012). Here, RAD51 is linked to colorectal cancer.